explore -WSS

explore

author：Wikipedia 2025-09-30 17:02:40 - browse：334

Cambridge: AbbVie — The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 — nearly a million dollars more than the company has ever spent in a single quarter. Ruby Wallau for STAT

WASHINGTON — The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 alone — more than any other drugmaker spent in the same period, and nearly a million dollars more than the company spent in the same period last year.

AbbVie was the seventh-highest corporate lobbying spender last quarter, ahead of giants like Lockheed Martin, CVS Health, and, AT&T, federal records show.

The number is eye-popping even for the pharmaceutical industry, which is known for its omnipresence on Capitol Hill, and its nearly unlimited lobbying budgets.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Boston's new lab space is opening empty

entertainment

WSS

Amid AI frenzy, a top HHS official's quest to create safeguards

No Labels group has 'steep climb,' but third party 'worth trying': Larry Hogan

How many hemophilia patients actually want gene therapy?

Ebola: Gilead Sciences antiviral shows promise as new treatment

Trump got a 'target letter.' What is one and what does it mean?

Medical experts are missing from AI regulatory conversations

hotspot

explore

leisure time

Novavax promises a turnaround & Lilly roils the obesity market

Pushing for an NIH office for post

Trump demands the U.S. pay no more for drugs than other countries … again

How many hemophilia patients actually want gene therapy?

23andMe had bad news about my health. I wish a person had delivered it

Acadia's Nuplazid fails as schizophrenia medicine in Phase 3 study

Medicare details structure of new drug price negotiation program

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

What does generative AI mean for health care? We asked experts

HHS secretary Becerra pressed on Change HealthCare cyberattack

entertainment

Steward Health Care Massachusetts hospitals face fiscal disaster

Why the Crimean Bridge is key to Russia's war in Ukraine

FDA advisers back CAR

Medical experts are missing from AI regulatory conversations

States increasingly look to regulate hospital facility fees

Why scientists need input from humanists on sensitive research

entertainment

entertainment

focus

hotspot